Bandaram Pharma Packtech Ltd Financials
Company Logo

Bandaram Pharma Packtech Ltd Financial Statement

Bandaram Pharma Packtech Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Mar 2025
Revenue3.80
Operating Expense3.75
Net Profit0.04
Net Profit Margin1.05
Earning Per Share0.04
EBIDTA0.05
Effective Tax Rate16.67

Bandaram Pharma Packtech Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual14.84
Operating Expenses Annual14.68
Operating Profit Annual0.19
Interest AnnualTBA
Depreciation0.02
Net Profit Annual0.13
Tax Annual0.04

Bandaram Pharma Packtech Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning0.09
Cash Flow from Operations-3.23
Cash Flow from Investing-1.40
Cash Flow from Financing4.61
Cash Flow at the End0.07

Bandaram Pharma Packtech Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)1.28
PBIT Margin (%)1.15
PBT Margin (%)1.15
Net PROFIT Margin (%)0.88
Return On Networth / Equity (%)1.70
Return On Networth /Employed (%)1.73
Return On Assets (%)1.32
Total Debt / Equity (X)0.29
Asset Turnover Ratio (%)1.51

Bandaram Pharma Packtech Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual0.01
Total Current Assets Annual9.43
Non Current Assets Annual3.92
Total Shareholders Funds Annual12.20
Total Assets Annual13.36

Bandaram Pharma Packtech Ltd Earning Calls

EPS (INR)

Expected

0.13

Reported

0.13

Surprise

0.00%

Dec 2024

EPS beaten by 0.00%

Sep 2024

EPS beaten by 0.00%

Jun 2024

EPS beaten by -44.64%

FAQS on Bandaram Pharma Packtech Ltd Financials

As of Jun 4, 2025, Bandaram Pharma Packtech Ltd has a market capitalization of 55.64 Cr. Value Research classifies it as a Micro-Cap company.

Yes, Bandaram Pharma Packtech Ltd is with a debt-to-equity ratio of 0.29.

In FY 2024 , Bandaram Pharma Packtech Ltd recorded a total revenue of approximately 12.23 Cr marking a significant milestone in the company's financial performance.

Bandaram Pharma Packtech Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.5% and 0.1% annually, respectively..

Bandaram Pharma Packtech Ltd's current PE ratio is 397.43.

Bandaram Pharma Packtech Ltd's ROCE averaged 2.1% from the FY ending March 2023 to 2025, with a median of 1.4%. It peaked at 3.6% in March 2023, reflecting strong capital efficiency over the period..

Bandaram Pharma Packtech Ltd's latest EBIT is Rs. 0.19 Cr, surpassing the average EBIT of Rs. 0.21 Cr over the 5 years..

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions